58 reports

Abstract: - Global Antidepressants Market to Reach $15.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Antidepressants estimated at US$14.2 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at a CAGR of 1% over the analysis period 2020-2027. Major...

  • Antidepressant
  • Anxiety Disorder
  • World
  • China
  • United States

Antidepressant Market Report Overview Antidepressant market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Antidepressant market types and applications. It is a focused study on Antidepressant market space including global and regional eight-year...

  • Antidepressant
  • World
  • Health Provider Density

Major players in the antidepressants market are Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, and Sun Pharmaceuticals Pvt Ltd. The global antidepressants market is expected to decline from $26.25 billion in 2020 to $15.87 billion in 2021...

  • Antidepressant
  • World
  • APAC
  • Antidepressant Medicine Sales
  • Depression Prevalence

Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs); Atypical Antipsychotics, Tricyclic Antidepressants (TCAs), Serotonin Antagonist and Reuptake Inhibitors (SARIs), Benzodiazepines; Monoamine Oxidase Inhibitors (MAOIs), Major Depressive Disorder (MDD), General Anxiety Disorder (GAD),...

  • Antidepressant
  • Anxiety Disorder
  • Hormone
  • World

KEY FINDINGS The global anti-depressant drugs, devices and therapies market is anticipated to grow at a CAGR of 1.81% CAGR during the year 2019-2027. The revenue generated by the market is expected to increase from $15,569 million in 2018 and reach $18,183 million by 2027. The antidepressant drugs, devices, and therapies...

  • Antidepressant
  • World
  • APAC

Abstract: - Global Food Amino Acids Market to Reach $9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Food Amino Acids estimated at US$5.8 Billion in the year 2020, is projected to reach a revised size of US$9 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027. Glutamic...

  • Antidepressant
  • World
  • China
  • United States

Abstract: - Global Premature Ejaculation Treatment Market to Reach $3.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Premature Ejaculation Treatment estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 7.4% over the analysis...

  • Dermatological Treatment
  • Tricyclic Antidepressant
  • World
  • China
  • United States

Chart ##: Tetracyclic Antidepressants

  • Antidepressant
  • China
  • Industrial Production
  • Labour Force

Premenstrual Syndrome Treatment Market by Drug Type (Analgesics, Antidepressants, Oral Contraceptives & Ovarian Suppression Agents, and Others), Type (Prescription and OTC), and Distribution Channel (Hospital Pharmacy, Drug Store & Retail Pharmacy, Online Providers): Global Opportunity Analysis and Industry Forecast, 2019–2026 The...

  • Pharmacy
  • In-Store Retail
  • Contraceptive
  • Analgesic
  • Antidepressant
  • World
  • APAC
  • Europe

The Global D-amino acid Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include high demand of domestic & synthetic peptides and peptide-based drugs, increasing adoption of advanced technologies...

  • Animal Feed
  • Artificial Sweetener
  • Pharmaceutical
  • Cosmetics
  • Beverage
  • Antidepressant
  • World

Narcolepsy Drugs Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026 Narcolepsy...

  • Therapy
  • Neurology
  • Tricyclic Antidepressant
  • World

Amino Acids Market Outlook and Growth Opportunities 2019- 2025 Global Amino Acids Market Outlook and Growth Opportunities to 2025: By Product Type (L-Glutamate, Lysine, Methionine, Threonine, Tryptophan, Leucine, Iso-Leucine, Valine, Glutamine, Arginine, Glycine, Phenylalanine, Tyrosine, Citrulline, Creatine, Proline,...

  • Animal Feed
  • Dietary Supplement
  • Supply Chain Management
  • Antidepressant
  • World

"US Depression Drug Market, Dosage, Price, Sales Insight 2021 - 2026" Report Highlights: • US Depression Drugs Market & Clinical Trial Insight • Comprehensive Insight On Approved Depression Drugs Price & Dosage Analysis For US Market • Depression Drugs Patent Timeline • Dosage, Formulation, Patent, Pricing...

  • Antidepressant
  • United States
  • Depression Prevalence
  • Drug Approval

The Global Feed Amino Acids Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market includes are protein demand for both human food and animal feed, rising cost of other natural feeds and embrace a broader range of amino acids in response to the escalating...

  • Shellfish
  • Cattle
  • Animal Feed
  • Aquaculture
  • Antidepressant
  • World

Germany Antidepressant Drugs Market

  • Antidepressant
  • World
  • Indiana
  • Health Expenditure
  • Depression Prevalence

Global Geriatric Medicines Market: Overview This report on the global geriatric medicines market analyzes the current and future prospects of the market.The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination...

  • In-Store Retail
  • Pharmacy
  • Environmental Services
  • Gastrointestinal Drug
  • Antidepressant
  • World

KEY FINDINGS The antidepressants drugs, devices and therapies market in Europe is undergoing an intensified growth of 1.77% CAGR during the forecasting years of 2019-2027. The rising population of depression has given an opportunity for the market in Europe to innovate the drug and therapies with the reduced side effects...

  • Antidepressant
  • Europe
  • World
  • Antidepressant Medicine Sales
  • Depression Prevalence

KEY FINDINGS The North American region is one the largest antidepressants drugs, devices, and therapies by diagnosed patients, devices manufacturers and establishment of several psychiatrists and psychologists that have contributed to the growth of the market at a CAGR of 1.27% during the forecasting years of 2019-2027. MARKET...

  • Antidepressant
  • North America
  • United States

Chart ##: Tetracyclic Antidepressants

  • Antidepressant
  • China
  • Labour Force
  • Industrial Production

KEY INSIGHTS The Asia Pacific is currently ranked third in terms of revenue from the depression drugs and devices market, where the expected growth rate of the antidepressants drugs, devices, and therapies market is 3.32% CAGR during the forecasting years of 2019-2027. MARKET INSIGHTS China, India,...

  • Antidepressant
  • APAC

D-amino Acid Market (Product - D-Alanine, D-Glutamic Acid, D-Aspartic Acid, D-Methionine, D-Threonine, D-Tryptophan, D-Leucine, D-Phenylalanine, D-Valine; End use Industry - Food and Beverages, Pharmaceutical, Cosmetics, Animal Feed) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026 D-amino...

  • Animal Feed
  • Artificial Sweetener
  • Pharmaceutical
  • Cosmetics
  • Beverage
  • Antidepressant
  • World

Antidepressants Import

  • Mental Health
  • Antipsychotic
  • Antidepressant
  • Psychotic Disorder
  • Dementia
  • China
  • Labour Force
  • Industrial Production

The global depression drugs market is expected to grow at a CAGR of 2.5% during 2019-2024. Depression drugs, or antidepressants, are a range of medications that are consumed for the treatment of mental disorders such as social anxiety and depression. They are intended to balance the functioning of neurotransmitters such as serotonin in the...

  • Antidepressant
  • World

2020 Tricyclic Antidepressants Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations This new report provides analysis of Tricyclic Antidepressants testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts...

  • In Vitro Diagnostic Reagent
  • Tricyclic Antidepressant
  • Europe
  • United States

This study covers the world outlook for antidepressants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Antidepressant
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for antidepressant pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antidepressant
  • Pharmaceutical
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for psychotherapeutic antidepressant agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antidepressant
  • World
  • United States
  • Disposable Income
  • Gross Domestic Product

This study covers the world outlook for psychotherapeutic agents excluding tranquilizers and antidepressants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is...

  • Antidepressant
  • World
  • United States
  • Disposable Income
  • Gross Domestic Product

There is an increasing tendency of women who have observed chronic vulvar pain once in a lifetime. If the pain is persistent for more than three months and has no apparent cause, it is called vulvodynia. It is estimated that 16% of women in the U.S. will have Vulvodynia at some point in their lives. According to the National Center for Biotechnology...

  • Antidepressant
  • Anesthetics
  • Tricyclic Antidepressant
  • United States
  • World

This study covers the world outlook for major depressive (MDD), obsessive-compulsive (OCD), generalized anxiety (GAD), and panic (PD) disorder antidepressants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of...

  • Anxiety Disorder
  • Depression
  • Personality Disorder
  • Antidepressant
  • World
  • Gross Domestic Product
  • Disposable Income